← Back
$URGN All transactions

UroGen Pharma Ltd.

▼ SELL

$ Value

$37K

Shares

2,203

Price

$17

Filed

Oct 9

Insider

Name

Degnan Chris

Title

Chief Financial Officer

CIK

0001741968

Roles

Officer

Transaction Details

Transaction Date

2025-10-08

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

2,280

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. | Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. | The reporting person was granted RSUs on October 8, 2024 representing 13,450 ordinary shares. The RSUs will vest in three equal annual installments from October 8, 2025.

Filing Info

Accession No.

0001437749-25-030772

Form Type

4

Issuer CIK

0001668243

Degnan Chris's History

Date Ticker Type Value
2026-01-31 URGN A $0
2025-10-08 URGN M
2025-10-08 URGN $37K
2025-10-08 URGN M $0

Other Insiders at URGN (90d)

Insider Bought Sold Last
Robinson James A. Jr. 2025-02-26
Degnan Chris
Chief Financial Officer
2026-01-31
Schoenberg Mark
Chief Medical Officer
$145K 2026-02-03
Barrett Elizabeth A.
Chief Executive Officer
2026-01-31
Smith Jason Drew
General Counsel
$147K 2026-02-03